{"name": "AbGenomics",
 "permalink": "abgenomics",
 "crunchbase_url": "http://www.crunchbase.com/company/abgenomics",
 "homepage_url": "http://abgenomics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "abg@abgenomics.com",
 "phone_number": "650-988-9912",
 "description": "",
 "created_at": "Tue Jun 11 04:38:46 UTC 2013",
 "updated_at": "Tue Jun 11 04:42:14 UTC 2013",
 "overview": "\u003Cp\u003EAbGenomics International Inc., incorporated in Delaware with principal office in SFO Bay Area California, is a biopharmaceutical company integrated globally and virtually to develop targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.\u003C/p\u003E\n\n\u003Cp\u003EWith its R\u0026amp;D foundation in Taipei Taiwan since June 2000, AbGenomics has been focusing on the discovery and development of novel therapeutics for the unmet medical needs.\u003C/p\u003E\n\n\u003Cp\u003EOur R\u0026amp;D scientists built an efficient discovery platform to identify and validate novel antibody therapeutics.\u003C/p\u003E\n\n\u003Cp\u003ECurrently, AbGenomics has several potential therapeutic antibodies targeting against autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors in various development stages.\u003C/p\u003E\n\n\u003Cp\u003ETo increase the efficacy and success rates, companion diagnostic methods specific for those therapeutics are also being developed. We intend to build a diversified product portfolio through our R\u0026amp;D and partnerships\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       100],
      "assets/images/resized/0027/3781/273781v1-max-150x150.png"],
     [[210,
       141],
      "assets/images/resized/0027/3781/273781v1-max-250x250.png"],
     [[210,
       141],
      "assets/images/resized/0027/3781/273781v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman \u0026 CEO",
    "person":
     {"first_name": "Rong-Hwa",
      "last_name": "Lin",
      "permalink": "rong-hwa-lin",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.bizjournals.com/sanjose/news/2013/06/10/autoimmune-drug-startup-abgenomics.html?ana=RSS\u0026s=article_search\u0026utm_source=twitterfeed\u0026utm_medium=twitter\u0026utm_campaign=Feed%3A+bizj_sanjose+%28Silicon+Valley+%2F+San+Jose+Business+Journal%29",
    "source_description": "Autoimmune drug startup AbGenomics raises $8M",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 6,
    "funded_day": 10,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "4984 El Camino Real",
    "address2": "",
    "zip_code": "94022",
    "city": "Los Altos",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        68],
       "assets/images/resized/0027/3780/273780v1-max-150x150.png"],
      [[250,
        113],
       "assets/images/resized/0027/3780/273780v1-max-250x250.png"],
      [[450,
        204],
       "assets/images/resized/0027/3780/273780v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}